What is NDC 60505-4779?

60505-4779 is the product NDC for Pazopanib, Pazopanib 200 mg/1 tablet, listed with the FDA by Apotex Corp.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Pazopanib?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Pazopanib NDC 60505-4779 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60505-4779Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60505-4779Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60505-4779-5	6050547790560505477905	500 TABLET in 1 BOTTLE (60505-4779-5)Marketed from Oct 19, 2023
60505-4779-7	6050547790760505477907	120 TABLET in 1 BOTTLE (60505-4779-7)Marketed from Oct 19, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pazopanib
Generic name (nonproprietary): pazopanib
Active ingredients: Pazopanib — 200 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Apotex Corp.NDC labeler code 60505
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217713
Marketing start: Oct 19, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2C8 Inhibitors (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Protein Kinase Inhibitors (Mechanism)
Identifiers: Product ID 60505-4779_aa77764e-b3cf-f1ac-d1df-373a0f325409SPL ID aa77764e-b3cf-f1ac-d1df-373a0f325409
Pharmacologic class: Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460505477905 followed by a unit qualifier and the quantity

Package 60505-4779-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 60505-4779

What is NDC 60505-4779?: 60505-4779 is the product NDC for Pazopanib, Pazopanib 200 mg/1 tablet, listed with the FDA by Apotex Corp.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Pazopanib.
What is the active ingredient?: Pazopanib.
Who is the labeler?: Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Pazopanib?: 7 other product NDCs are listed under this name. See all Pazopanib NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Pazopanib NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
pazopanibpazopanib hydrochloride	Pazopanib hydrochloride 400 mg/1	Tablet, Film coatedOral	Torrent Pharmaceuticals Limited	13668-735	13668-0735-3013668-0735-6013668-0735-90
Pazopanib	Pazopanib hydrochloride 200 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-582	59651-0582-0859651-0582-3059651-0582-90
pazopanibpazopanib hydrochloride	Pazopanib hydrochloride 200 mg/1	Tablet, Film coatedOral	Novugen Pharma (USA) LLC.	82293-022	82293-0022-10
Pazopanib	Pazopanib hydrochloride 200 mg/1	Tablet, Film coatedOral	AvKARE	42291-939	42291-0939-12
Pazopanib	Pazopanib hydrochloride 200 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals, Inc.	0480-4184	00480-4184-89
Pazopanib	Pazopanib hydrochloride 200 mg/1	Tablet, Film coatedOral	SUN PHARMACEUTICAL INDUSTRIES, INC.	63304-116	63304-0116-1363304-0116-30
Pazopanib	Pazopanib 200 mg/1	TabletOral	Golden State Medical Supply, Inc.	51407-872	51407-0872-12

Other NDCs under ANDA 217713

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217713
Product	Strength	Form · route	Labeler	Product NDC
Pazopanib	Pazopanib 200 mg/1	TabletOral	Golden State Medical Supply, Inc.	51407-872